The role of TNF-α in a murine model of Kawasaki disease arteritis induced with a Candida albicans cell wall polysaccharide

Cutaneous vasculitis induced by TNF inhibitors: a report of three cases

(2014) Keita Fujikawa et al.   Modern Rheumatology

Administration of human immunoglobulin suppresses development of murine systemic vasculitis induced withCandida albicanswater-soluble fraction: an animal model of Kawasaki disease

(2014) Kei Takahashi et al.   Modern Rheumatology

Epidemiologic Features of Kawasaki Disease in Japan: Results of the 2009–2010 Nationwide Survey

(2012) Yosikazu Nakamura et al.   JOURNAL OF EPIDEMIOLOGY

Efficacy and Limitation of Infliximab Treatment for Children with Kawasaki Disease Intractable to Intravenous Immunoglobulin Therapy: Report of an Open-label Case Series

(2012) M. MORI et al.   JOURNAL OF RHEUMATOLOGY

Prospective Open-Label Trial of Etanercept as Adjunctive Therapy for Kawasaki Disease

(2010) Nadine F. Choueiter et al.   JOURNAL OF PEDIATRICS

Infliximab for Intravenous Immunoglobulin Resistance in Kawasaki Disease: A Retrospective Study

(2010) Mary Beth Son et al.   JOURNAL OF PEDIATRICS

IL-10 Is a Negative Regulatory Factor of CAWS-Vasculitis in CBA/J Mice as Assessed by Comparison with Bruton's Tyrosine Kinase-Deficient CBA/N Mice

(2009) N. N. Miura et al.   JOURNAL OF IMMUNOLOGY

Infliximab Reduces the Cytokine-Mediated Inflammation but Does Not Suppress Cellular Infiltration of the Vessel Wall in Refractory Kawasaki Disease

(2009) Keiichi Hirono et al.   PEDIATRIC RESEARCH

Evaluation of the anti-inflammatory effect of infliximab in a mouse model of acute asthma

(2008) Figen DEVECI et al.   RESPIROLOGY

Inhibition of TNF-α reduces transplant arteriosclerosis in a murine aortic transplant model

(2008) Martina Wollin et al.   TRANSPLANT INTERNATIONAL